• Home
      • StockReports™Analyse your stocks in seconds
      • Stock ResearchExpert insight you can understand
      • StockRanks™Identify winning stocks
      • ScreenersGenerate investing ideas fast
      • PortfoliosMonitor and improve your performance
      • Charts and toolsTime your trades better
      • Academy
        • All topics
        • Analyse stocks
        • Discover stocks
        • Investment strategy
        • Portfolio management
      • Additional resources
        • Events
        • Product guides
        • Ratio glossary
        • Newsletter
        • Companies & markets
    • Reviews
    • Pricing
    • About
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchSolvonis Therapeutics
    Picture of Solvonis Therapeutics logo

    SVNS — Solvonis Therapeutics Share News

    0.35p0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    • Market Cap
      £22.41m
    • Enterprise Value
      £20.77m
    • Revenue
    • Quality
      21
    • Value
      10
    • Momentum
      91
    • StockRank™
      30
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SVNS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SVNS Dividends
    • RCS - Solvonis Therapeutic - Presentation at PharmaSynergyRx Event

      25/02/2025 07:00Announcement
    • REG - Solvonis Therapeutic - Entry into an Arrangement Agreement with Awakn

      24/02/2025 07:00Announcement
    • RCS - Solvonis Therapeutic - Proactive Investors interview with Chairman

      30/01/2025 12:00Announcement
    • REG - Solvonis Therapeutic - Update on Awakn Life Sciences’ R&D Progress

      27/01/2025 07:00Announcement
    • RCS - Solvonis Therapeutic - Investor Presentation

      24/01/2025 07:00Announcement
    • RCS - Solvonis Therapeutic - Proactive Investors interview with CEO

      21/01/2025 14:30Announcement
    • REG - Solvonis Therapeutic - Update on FDA Pre-IND Meeting for Awakn

      21/01/2025 07:00Announcement
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2025, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.